Sort by
Medicine and Dentistry
Glioblastoma
100%
Stereotactic Radiosurgery
80%
Neoplasm
74%
Brain Metastasis
69%
Intracranial Tumor
65%
Ganglioglioma
51%
Radiation Therapy
41%
Bevacizumab
38%
Magnetic Resonance Imaging
36%
Metastatic Carcinoma
34%
Meningioma
31%
Posterior Fossa
28%
Embolization
28%
Neurosurgery
27%
Overall Survival
23%
Brain Tissue
23%
Arteriovenous Malformation
23%
Arm
21%
Whole Brain Radiotherapy
20%
Quality of Life
20%
Craniotomy
19%
Clinical Trial
17%
Oncology
16%
Phase III Trials
15%
Radiosurgery
15%
Third Ventriculostomy
14%
Pneumocephalus
14%
Dose Calculation
14%
Cancer Surgery
14%
Cerebral Arteriovenous Malformation
14%
Recursive Partitioning
14%
Tumor Treating Fields
14%
Biological Marker
14%
Pediatrics Patient
14%
Stereotactic Treatment
14%
Intraoperative MRI
14%
Spinal Cord Tumor
14%
Treatment Planning
14%
Subventricular Zone
14%
Temozolomide
13%
Diseases
13%
Biopsy Technique
12%
Gemistocyte
12%
Brain Radiation
12%
Ischemia
11%
Retrospective Study
11%
Thromboembolism
10%
Epileptic Seizure
10%
Treatment Response
10%
Recurrent Disease
10%
Keyphrases
Stereotactic Radiosurgery
88%
Brain Metastases
82%
Glioblastoma
64%
Bevacizumab
44%
High-grade Glioma
36%
Temozolomide
36%
Brain Tumor
28%
Tumor Treating Fields
28%
Tumor
27%
Newly Diagnosed Glioblastoma
26%
Stereotactic Treatment
25%
Onyx
25%
Radiotherapy
24%
Meningioma
24%
Arteriovenous Malformation
23%
S100
21%
Randomized Clinical Trial
21%
Glioblastoma multiforme
21%
Posterior Fossa Metastasis
21%
Craniotomy
21%
Chemotherapy
20%
Whole Brain Radiotherapy
19%
Radiation Therapy
19%
Microdialysis
18%
Magnetic Resonance Imaging
18%
Overall Survival
17%
Oligodendroglioma
17%
Progression-free Survival
16%
Onyx Embolization
15%
Intraoperative Magnetic Resonance Imaging (iMRI)
15%
Resection
14%
Surgical Removal
14%
Intraoperative Imaging
14%
Recursive Partitioning Analysis
14%
Randomized Phase III Trial
14%
Endoscopic Third Ventriculostomy
14%
Pneumocephalus
14%
Resection Cavity
14%
Health-related Quality of Life
14%
Cerebral Arteriovenous Malformation
14%
Spinal Tumor
14%
Physician Choice
14%
Risk Factors
14%
RTOG 0933
14%
Brain Tumor Surgery
13%
Patient Selection
13%
Brain Tissue
13%
Neurosurgery
12%
Gemistocytes
12%
Clinical Trials
12%